About this trial
TRUST Registry is an observational, prospective, long-term, post-market surveillance registry of subjects treated with WallabyPhenox flow modulation devices, stent systems, bifurcation aneurysm implants including their HPC variants (Hydrophilic Polymer Coating) where applicable as well as coil systems, and other adjunctive medical devices.
The overarching purpose of this registry is to carry out a proactive gathering, recording, and analysis of data on the safety, performance and usability of the devices as applied within the routine practice of the participating registry sites.
Eligibility criteria
Qualifiers
Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject),
Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation.
Disqualifiers
Participation in an interventional study modifying standard care management for all relevant indications,
Trial design
Treatments tested in this trial
- Aneurysm Treatment with a Neurovascular Flow Diverter
- Dissection Treatment with a Neurovascular Flow Diverter
- Perforation Treatment with a Neurovascular Flow Diverter
- Arteriovenous Fistula treatment with a Neurovascular Flow Diverter
- Aneurysm Treatment with Neurovascular Stent System
- Atherosclerotic vascular stenosis Treatment with Neurovascular Stent System
- Dissection Treatment with Neurovascular Stent System
- Aneurysm treatment with Bifurcation Aneurysm Implant
- Aneurysm treatment with Avenir Coil System
- Arteriovenous fistula treatment with Avenir Coil System